Manion Maura, Uldrick Thomas, Polizzotto Mark N, Sheikh Virginia, Roby Gregg, Lurain Kathryn, Metzger Dorinda, Mican JoAnn M, Pau Alice, Lisco Andrea, Laidlaw Elizabeth, Hammoud Dima A, Whitby Denise, Yarchoan Robert, Sereti Irini
National Institute of Allergy and Infectious Disease, National Institutes of Health (NIH), Bethesda, Maryland.
National Cancer Institute, NIH, Bethesda, Maryland.
Open Forum Infect Dis. 2018 Oct 12;5(10):ofy217. doi: 10.1093/ofid/ofy217. eCollection 2018 Oct.
Corticosteroid use was associated with development of Kaposi's sarcoma or multicentric Castleman disease in 3 patients with mycobacterial immune reconstitution inflammatory syndrome (IRIS) treated with corticosteroids. Monitoring for development of Kaposi's sarcoma and alternative treatment may be beneficial for patients with IRIS, especially in the presence of preexisting co-infection with Kaposi's sarcoma-associated herpesvirus.
在3例接受皮质类固醇治疗的分枝杆菌免疫重建炎症综合征(IRIS)患者中,使用皮质类固醇与卡波西肉瘤或多中心Castleman病的发生有关。对卡波西肉瘤的发生进行监测并采用替代治疗可能对IRIS患者有益,尤其是在存在与卡波西肉瘤相关疱疹病毒的既往合并感染的情况下。